Table 3.

Univariate analysis for OS in younger GBM patients (age < 60 yrs) of TCGA database

Variable	No.(%)	Median OS (months)	P	Median PFS (months)	P
Gender			0.002		0.131
Male	78 (57.78)	15.39		7.86
Female	57 (42.22)	22.49		8.48
LANCL2 gene status			0.054		0.177
Amplification	33 (24.44)	15.02		5.85
No alteration	102 (75.56)	18.08		8.48
EGFR gene status			0.128		0.795
Amplification	56 (41.48)	17.49		8.12
No alteration	79 (58.52)	17.79		7.63
LANCL2 and EGFR genes status			0.054		0.177
Co-amplification	33 (24.44)	15.02		5.85
No alteration	102 (75.56)	18.08		8.48